Related references
Note: Only part of the references are listed.Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells
James Ahodantin et al.
CARCINOGENESIS (2020)
A phase II study of onvansertib in combination with abiraterone and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC).
David Johnson Einstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Developing polo-like kinase 1 inhibitors
Xufeng Huang et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy
Shazi Shakil et al.
SEMINARS IN CANCER BIOLOGY (2019)
Polo-like kinases and acute leukemia
Oksana Goroshchuk et al.
ONCOGENE (2019)
A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair
Weizhe Li et al.
SCIENCE ADVANCES (2019)
Kinome-Wide Screening with Small Interfering RNA Identified Polo-like Kinase 1 as a Key Regulator of Proliferation in Oral Cancer Cells
Yih-Gang Goan et al.
CANCERS (2019)
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer
Antonio Giordano et al.
PLOS ONE (2019)
Plk1 phosphorylation of Numb leads to impaired DNA damage response
C. Shao et al.
ONCOGENE (2018)
Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin
Zhiguo Li et al.
CANCER RESEARCH (2018)
Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia
Daniel T. Merrick et al.
CANCER RESEARCH (2018)
Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer
Fengyi Mao et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Plk1 overexpression induces chromosomal instability and suppresses tumor development
Guillermo de Carcer et al.
NATURE COMMUNICATIONS (2018)
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas
Yuan Ren et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3
Sonja I. Gringhuis et al.
NATURE IMMUNOLOGY (2017)
Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice
Zhiguo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
PLK1, A Potential Target for Cancer Therapy
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2017)
Regulatory functional territory of PLK-1 and their substrates beyond mitosis
Shiv Kumar et al.
ONCOTARGET (2017)
Identification of Polo-like kinases as potential novel drug targets for influenza A virus
Marie O. Pohl et al.
SCIENTIFIC REPORTS (2017)
The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation
Linda Smith et al.
SCIENTIFIC REPORTS (2017)
Development of Bifunctional Inhibitors of Polo-Like Kinase1 with Low-Nanomolar Activities Against the Polo-Box Domain
Andrej Scharow et al.
CHEMBIOCHEM (2016)
Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer
Ujjwal M. Mahajan et al.
GUT (2016)
Cytotoxic mechanism of PLK1 inhibitor GSK461364 against osteosarcoma: mitotic arrest, apoptosis, cellular senescence, and synergistic effect with paclitaxel
Yi-Sheng Chou et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor
J. Van den Bossche et al.
MEDICINAL RESEARCH REVIEWS (2016)
Long noncoding RNA lnc-RI is a new regulator of mitosis via targeting miRNA-210-3p to release PLK1 mRNA activity
Zhi-Dong Wang et al.
SCIENTIFIC REPORTS (2016)
Core protein: A pleiotropic keystone in the HBV lifecycle
Adam Zlotnick et al.
ANTIVIRAL RESEARCH (2015)
Crystal structure of the polo-box domain of polo-like kinase 2
Hong-Mei Shan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells
Lina Yang et al.
CANCER LETTERS (2015)
Phosphorylation of SAF-A/hnRNP-U Serine 59 by Polo-Like Kinase 1 Is Required for Mitosis
Pauline Douglas et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis
Ruitao Zhang et al.
ONCOLOGY REPORTS (2015)
Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy
Kyung S. Lee et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The chromatin remodeller RSF1 is essential for PLK1 deposition and function at mitotic kinetochores
Ho-Soo Lee et al.
NATURE COMMUNICATIONS (2015)
PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
Verena Thalhammer et al.
CANCER RESEARCH (2015)
Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing
Julia K. Pagan et al.
NATURE CELL BIOLOGY (2015)
Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer
Joshua A. McCarroll et al.
ONCOTARGET (2015)
Polo-like kinases: structural variations lead to multiple functions
Sihem Zitouni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Thymoquinone Blocks pSer/pThr Recognition by Plk1 Polo-Box Domain As a Phosohate Mimic
Zhou Yin et al.
ACS CHEMICAL BIOLOGY (2013)
Identification of potential synthetic lethal genes to p53 using a computational biology approach
Xiaosheng Wang et al.
BMC MEDICAL GENOMICS (2013)
Centrosomal protein FOR20 is essential for S-phase progression by recruiting Plk1 to centrosomes
Minhong Shen et al.
CELL RESEARCH (2013)
Plk1: unexpected roles in DNA replication
Ranadip Mandal et al.
CELL RESEARCH (2013)
Ubiquitylation-dependent localization of PLK1 in mitosis
Jochen Beck et al.
NATURE CELL BIOLOGY (2013)
MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes
Jie He et al.
NUCLEIC ACIDS RESEARCH (2013)
Identification of novel, potent and selective inhibitors of Polo-like kinase 1
Shaoqing Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours
Patrick Schoffski et al.
EUROPEAN JOURNAL OF CANCER (2012)
Cdk1 and Plk1 mediate a CLASP2 phospho-switch that stabilizes kinetochore-microtubule attachments
Ana R. R. Maia et al.
JOURNAL OF CELL BIOLOGY (2012)
Polo-like kinase-1 regulates kinetochore-microtubule dynamics and spindle checkpoint silencing
Dan Liu et al.
JOURNAL OF CELL BIOLOGY (2012)
Oscillation of APC/C activity during cell cycle arrest promotes centrosome amplification
Suzanna L. Prosser et al.
JOURNAL OF CELL SCIENCE (2012)
The where, when and how of microtubule nucleation - one ring to rule them all
Neus Teixido-Travesa et al.
JOURNAL OF CELL SCIENCE (2012)
TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens
Yuichi Hikichi et al.
MOLECULAR CANCER THERAPEUTICS (2012)
NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies
Barbara Valsasina et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Switching Polo-like kinase-1 on and off in time and space
Wytse Bruinsma et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma
Wei Chuen Mok et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
Bing Song et al.
CELL DIVISION (2012)
Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease
Bing Song et al.
AGING-US (2011)
Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase
Sean C. Semple et al.
CANCER RESEARCH (2011)
Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets
Yan Ding et al.
CANCER RESEARCH (2011)
Polo-like kinase 1 inhibitors SBE13 and BI 2536 induce different responses in primary cells
Frank Eckerdt
CELL CYCLE (2011)
Phosphorylation of Ataxin-10 by polo-like kinase 1 is required for cytokinesis
Jing Li et al.
CELL CYCLE (2011)
From Plk1 to Plk5 Functional evolution of Polo-like kinases
Guillermo de Carcer et al.
CELL CYCLE (2011)
Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
Balca R. Mardin et al.
CURRENT BIOLOGY (2011)
The Plk1-dependent Phosphoproteome of the Early Mitotic Spindle
Anna Santamaria et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Plk1 Phosphorylation of Orc2 Promotes DNA Replication under Conditions of Stress
Bing Song et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Plk1-Targeted Small Molecule Inhibitors: Molecular Basis for Their Potency and Specificity
Ravichandran N. Murugan et al.
MOLECULES AND CELLS (2011)
Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD
M-S Jang et al.
ONCOGENE (2011)
Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
Karoline V. Gleixner et al.
CANCER RESEARCH (2010)
Targeting Polo-like Kinase in Cancer Therapy
Yan Degenhardt et al.
CLINICAL CANCER RESEARCH (2010)
Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma
Chunling Zhao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Polo-Like Kinase 1 Is Involved in Hepatitis C Virus Replication by Hyperphosphorylating NS5A
Yung-Chia Chen et al.
JOURNAL OF VIROLOGY (2010)
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
Klaus Strebhardt
NATURE REVIEWS DRUG DISCOVERY (2010)
Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase
Hongchang Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Susanne M. A. Lens et al.
NATURE REVIEWS CANCER (2010)
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
Kyle A. Emmitte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors
Yoshiyuki Sato et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis
Wolfgang Reindl et al.
CHEMBIOCHEM (2009)
Identification and Validation of a Potent Type II Inhibitor of Inactive Polo-like Kinase 1
Sarah Keppner et al.
CHEMMEDCHEM (2009)
Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover
Sylvia S. Dias et al.
FEBS LETTERS (2009)
Polo-Like Kinase 1 Inhibition Suppresses Hepatitis B Virus X Protein-Induced Transformation in an In Vitro Model of Liver Cancer Progression
Leo L. Studach et al.
HEPATOLOGY (2009)
Polo-Like Kinase 1 Depletion Induces DNA Damage in Early S Prior to Caspase Activation
Hyungshin Yim et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Polo-like kinases: conservation and divergence in their functions and regulation
Vincent Archambault et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
Sang-Moon Yun et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay
A. Jimeno et al.
ONCOGENE (2009)
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin
Tiago M. Bandeiras et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors
Emily J. Hanan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors
Raymond V. Fucini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Ligand discovery and virtual screening using the program LIDAEUS
P. Taylor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Inhibition of polo-like kinase 1 by blocking Polo-box domain-dependent protein-protein interactions
Wolfgang Reindl et al.
CHEMISTRY & BIOLOGY (2008)
Role for Plk1 phosphorylation of Hbo1 in regulation of replication licensing
Zhao-Qiu Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
Kyung S Lee et al.
Cell Division (2008)
Selectivity-determining residues in Plk1
Michael Kothe et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Use of the novel Plk1 inhibitor ZK-Thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis
Anna Santamaria et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Pharmacological and functional comparison of the polo-like kinase family: Insight into inhibitor and substrate specificity
Eric F. Johnson et al.
BIOCHEMISTRY (2007)
Structure of the catalytic domain of human polo-like kinase 1
Michael Kothe et al.
BIOCHEMISTRY (2007)
Probing cell-division phenotype space and Polo-like kinase function using small molecules
Ulf Peters et al.
NATURE CHEMICAL BIOLOGY (2006)
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
Campbell McInnes et al.
NATURE CHEMICAL BIOLOGY (2006)
A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors
Linda L. Garland et al.
CLINICAL CANCER RESEARCH (2006)
Polo-like kinases - A team in control of the division
Barbara C. M. van de Weerdt et al.
CELL CYCLE (2006)
Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6
A Incassati et al.
ONCOGENE (2006)
Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways
N Watanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Small interfering RNA-mediated polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals
R Guan et al.
CANCER RESEARCH (2005)
Progress in the discovery of polo-like kinase inhibitors
C McInnes et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma
Y Ito et al.
BRITISH JOURNAL OF CANCER (2004)
Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection
P Bostik et al.
JOURNAL OF VIROLOGY (2004)
Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells
C Lindon et al.
JOURNAL OF CELL BIOLOGY (2004)
Polo-like kinase I is overexpressed in prostate cancer and linked to higher tumor grades
W Weichert et al.
PROSTATE (2004)
Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation
K Ando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Polo-like kinases and the orchestration of cell division
FA Barr et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex
KY Cheng et al.
EMBO JOURNAL (2003)
The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain
AEH Elia et al.
CELL (2003)
Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation
M Casenghi et al.
DEVELOPMENTAL CELL (2003)
A Role for Plk1 phosphorylation of NudC in cytokinesis
T Zhou et al.
DEVELOPMENTAL CELL (2003)
Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells
XQ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates
AEH Elia et al.
SCIENCE (2003)
Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
T Takahashi et al.
CANCER SCIENCE (2003)
Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells
B Spänkuch-Schmitt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase
YJ Jang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease
L Kneisel et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2002)
Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA
XQ Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells
B Spänkuch-Schmitt et al.
ONCOGENE (2002)
Essential function of the polo box of Cdc5 in subcellular localization and induction of cytokinetic structures
S Song et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
